Rebecca Adams received her BA in Medical Sciences and BMBCh from Oxford University. before undertaking clinical academic training across Wales and London. Specialising in dermatology, she has always had an interest in immunology, and specifically the immunology of skin cancer. She has been awarded an MRC Clinical Research Fellowship and is currently undertaking her PhD with the Karagiannis Group. Her project focusses on the role anti-cancer-antigen monoclonal antibodies can play in manipulating the immune response of monocytes and macrophages in the context of melanoma.